Aller au contenu principal
Profil bibliographique

Keng‐Liang Wu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

126Publications signalées
2501Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Gastroesophageal reflux and treatmentsHelicobacter pylori-related gastroenterology studiesEsophageal and GI PathologyGastric Cancer Management and OutcomesEosinophilic Esophagitis

Les publications récentes

Accès ouvert 2025 article OpenAlex

Alternation of the oral, gastric and stool microbiome in patients with reflux esophagitis and Barrett's esophagus

Chih‐Chien Yao, Wei-Chen Tai, Chih-Ming Liang, Ming‐Chao Tsai et autres

BACKGROUND: The imbalance of human microbiota has been associated with various inflammatory disease. Compared to intestinal flora, the esophageal microbiome has been understudied,and it remains unclear whether dysbiosis is related to reflux esophagitis (RE) and Barrett's esophagus (BE).This study aimed to synthesize …

tw, cn (code pays fourni par la source)

1 citation Journal of Microbiology Immunology and Infection
2025 conference-paper OpenAlex

Fan-out RDL process and shuttle service

Chen-Chun Yu, Yi-Shu Chen, Yuan‐Chang Lee, Huan‐Chun Fu et autres

With the rapid advancement of artificial intelligence (AI) technologies, AI chips have emerged as a cornerstone in enabling high-performance and data-intensive applications. A wide spectrum of related products is actively exploring approaches to integrate AI functionality. A defining characteristic of such innovative …

tw (code pays fourni par la source)

0 citations
2024 conference-paper OpenAlex

Fan-out RDL Packaging Process and Shuttle Service

Chen-Chun Yu, Hsiang‐Hung Chang, Yi-Shu Chen, Yuan‐Chang Lee et autres

With the rapid development of AI technology, AI chips have become a cornerstone of high-end technological applications. Various related products are actively exploring ways to integrate AI technology. A hallmark of innovative products and startups is their need for diverse, small-batch manufacturing. …

tw (code pays fourni par la source)

0 citations
Accès ouvert 2023 article OpenAlex

Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study

Wei‐Chen Lin, Wei‐Chen Tai, Chung‐Hsin Chang, Chia‐Hung Tu et autres

BACKGROUND: This nationwide prospective registry study investigated the real-world effectiveness, safety, and persistence of vedolizumab (VDZ) in inflammatory bowel disease (IBD) patients in Taiwan. Disease relapse rates after VDZ discontinuation due to reimbursement restriction were assessed. METHODS: Data were collected prospectively (January …

tw (code pays fourni par la source)

24 citations Inflammatory Bowel Diseases
Accès ouvert 2022 article OpenAlex

Extremity risk factors of sepsis for gastrointestinal endoscopy in patients with liver cirrhosis

Yi‐Chia Chan, Chao‐Long Chen, Chih‐Chi Wang, Chih‐Che Lin et autres

BACKGROUND: Liver cirrhosis is a well-known risk factor of sepsis after emergent gastrointestinal (GI) endoscopy. Elective GI endoscopy before living donor liver transplantation (LDLT), however, may also carry the septic risk among these patients. METHODS: This retrospective study reviewed the medical records …

tw (code pays fourni par la source)

4 citations BMC Gastroenterology
2022 article OpenAlex

[Safety evaluation of hyperthermic intraperitoneal chemotherapy in patients with local advanced gastric cancer after radical resection for prevention of peritoneal metastasis].

Yecheng Lin, Chao Shen, Xiangling Guo, Y Li et autres

Radical surgery + HIPEC does not significantly increase the incidence of perioperative complications in patients with advanced gastric cancer. The age >60 years and nerve invasion are independent risk factors for adverse events in these patients.

hk, cn (code pays fourni par la source)

1 citation PubMed
Accès ouvert 2021 article OpenAlex

The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study

Chia‐Jung Kuo, Puo‐Hsien Le, Wei‐Chen Tai, Keng‐Liang Wu et autres

BACKGROUND: The use of biologic agents has become the cornerstone of therapy for moderate to severe IBD. Few studies have investigated the efficacy of vedolizumab (VDZ) induction for ulcerative colitis (UC) in Asian patients in a real practice setting. AIMS: To evaluate …

tw (code pays fourni par la source)

10 citations Journal of the Formosan Medical Association
Accès ouvert 2021 article OpenAlex

Per oral endoscopic myotomy for achalasia: A Taiwanese single‐center experience

Yu‐Chi Lee, Wei‐Chen Tai, Keng‐Liang Wu, Chih‐Chien Yao et autres

Abstract Endoscopic treatment of achalasia includes endoscopic botulinum toxin injection, endoscopic pneumatic dilations (PD) but surgery owns longer durability. Per oral endoscopic myotomy (POEM) carries high expectations with good short and mid‐term report and only minor morbidity in Western and Eastern countries …

tw (code pays fourni par la source)

0 citations Advances in digestive medicine
2021 conference-abstract OpenAlex

P425 Real-world evidence on effectiveness and safety of vedolizumab therapy for inflammatory bowel disease in Taiwan: Results from the TSIBD registry (VIOLET Study)

Shu‐Chen Wei, Wei‐Chen Lin, Chung‐Hsing Chang, Chia‐Hung Tu et autres

Abstract Background GEMINI trials and real-world studies in Western population have demonstrated the effectiveness and safety of vedolizumab (VDZ) for IBD. However, long-term real-world evidence of VDZ in Asian populations remains limited. This study aimed to investigate the effectiveness and safety of …

tw (code pays fourni par la source)

2 citations Journal of Crohn s and Colitis
Accès ouvert 2021 article OpenAlex

An update on endoscopic treatment for achalasia: From per oral endoscopic myotomy to endolumenal functional lumen imaging probe

Wei‐Chen Tai, Keng‐Liang Wu, Seng‐Kee Chuah

Traditional endoscopic treatment of achalasia includes endoscopic local injection of botulinum toxin into the lower esophageal sphincter (LES) muscle, endoscopic balloon dilations.1, 2 Injection of botulinum toxin is safe and only may be associated with minor complications but the main drawback is …

tw (code pays fourni par la source)

0 citations Advances in digestive medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.